ONKURE THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-42.1M | $53.6M |
| FY2021 | — | $147.2M | $124.7M |
| FY2022 | — | $-54.4M | $19.9M |
| FY2023 | — | $-101.8M | $29.9M |
| FY2024 | — | $103.8M | $110.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-42.1M | $53.6M |
| FY2021 | — | $147.2M | $124.7M |
| FY2022 | — | $-54.4M | $19.9M |
| FY2023 | — | $-101.8M | $29.9M |
| FY2024 | — | $103.8M | $110.8M |